# Fast & Fed Pharmacokinetic (PK) Study

> **NCT00692016** · PHASE1 · COMPLETED · sponsor: **Bayer** · enrollment: 32 (actual)

## Conditions studied

- Bioavailability

## Interventions

- **DRUG:** Naproxen sodium
- **DRUG:** Naproxen sodium

## Key facts

- **NCT ID:** NCT00692016
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2008-02
- **Final completion:** 2008-03
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2013-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00692016

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00692016, "Fast & Fed Pharmacokinetic (PK) Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00692016. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*